Bipolar II Disorder
Neurology·MeSH: Psychotic Disorders
Prevalence
463.1 / 100K
Incidence
32.5 / 100K/yr
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| nmra-335140 | Neumora Therapeutics, Inc. (NMRA) |
Frequently asked questions
How many drugs are in development for Bipolar II Disorder?
BioSniper tracks 1 drug in development for Bipolar II Disorder across 1 company.
How many clinical trials target Bipolar II Disorder?
There are 4 clinical trials targeting Bipolar II Disorder tracked by BioSniper.
What is the prevalence of Bipolar II Disorder?
The estimated prevalence of Bipolar II Disorder is approximately 463.1 per 100,000 population.
Deep-dive into Bipolar II Disorder
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis